Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE

被引：0

作者：

Papi, A. ^{[1
]}

Bourdin, A. ^{[2
]}

Watz, H. ^{[3
]}

Pavord, I. D. ^{[4
]}

Domingo, C. ^{[5
]}

Wechsler, M. E. ^{[6
]}

Mao, X. ^{[7
]}

Ortiz, B. ^{[8
]}

Djandji, M. ^{[9
]}

Mannent, L. P. ^{[10
]}

Ruddy, M. ^{[8
]}

Laws, E. ^{[7
]}

Amin, N. ^{[8
]}

Lederer, D. J. ^{[8
]}

Hardin, M. ^{[9
]}

机构：

[1] Univ Ferrara, S Anna Univ Hosp, Resp Med Unit, Ferrara, Italy

[2] Montpellier Univ Hosp, Montpellier, France

[3] German Ctr Lung Res DZL, Airway Res Ctr North ARCN, LungenClin Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany

[4] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England

[5] Autonomous Univ Barcelona, Sabadell, Corp Sanitaria Parc Tauli, Barcelona, Spain

[6] Natl Jewish Hlth, Denver, CO USA

[7] Sanofi, Bridgewater, NJ USA

[8] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[9] Sanofi, Cambridge, MA USA

[10] Sanofi, Chilly Mazarin, France

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A1460

引用

页数：1

共 50 条

[31] Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study
Maspero, Jorge F.
Peters, Anju T.
Chapman, Kenneth R.
Domingo, Christian
Stewart, John
Hardin, Megan
Maroni, Jaman
Tawo, Kelsey
Khokhar, Faisal A.
Mortensen, Eric
Laws, Elizabeth
Radwan, Amr
Jacob-Nara, Juby A.
Deniz, Yamo
Rowe, Paul J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (04): : 991 - 997.e6
[32] DUPILUMAB LEADS TO CLINICAL ASTHMA REMISSION INDICATIVE OF COMPREHENSIVE IMPROVEMENT IN PATIENTS WITH ASTHMA: RESULTS FROM THE LIBERTY ASTHMA QUEST AND TRAVERSE STUDIES
Douglass, Jo A.
Pavord, Ian D.
Brusselle, Guy G.
Rabe, Klaus F.
Menzies-Gow, Andrew
Moody, Jana
Altincatal, Arman
Pandit-Abid, Nami
Lederer, David J.
Zhang, Yi
Rowe, Paul J.
Deniz, Yamo
Radwan, Amr
Jacob-Nara, Juby A.
Busse, William W.
INTERNAL MEDICINE JOURNAL, 2022, 52 : 18 - 18
[33] Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study
Pavord, Ian Douglas
Fitzgerald, J. Mark
Brusselle, Guy
Wenzel, Sally E.
Rabe, Klaus F.
Busse, William W.
Papi, Alberto
Rice, Megan S.
Deniz, Yamo
Rowe, Paul
Amin, Nikhil
Graham, Neil M. H.
Teper, Ariel
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[34] LONG-TERM EFFICACY OF DUPILUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA IN THE LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY: IMPROVEMENTS IN ASTHMA CONTROL AND HEALTH-RELATED QUALITY OF LIFE
Pavord, I. D.
Wechsler, M. E.
Ford, L. B.
Maspero, J. F.
Langton, D.
Domingo, C.
Papi, A.
Bourdin, A.
Watz, H.
Mao, X.
Amin, N.
Hardin, M.
Zhang, Y.
Khan, A. H.
THORAX, 2021, 76 : A91 - A92
[35] Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma
Corren, Jonathan
Katelaris, Constance H.
Castro, Mario
Maspero, Jorge F.
Humbert, Marc
Halpin, David M. G.
Altincatal, Arman
Pandit-Abid, Nami
Soler, Xavier
Radwan, Amr
Jacob-Nara, Juby A.
Deniz, Yamo
Rowe, Paul J.
ERJ OPEN RESEARCH, 2023, 9 (05)
[36] LONG-TERM ASSESSMENT OF EXACERBATIONS AND LUNG FUNCTION IN THE LIBERTY ASTHMA TRAVERSE STUDY, STRATIFIED BY LUNG FUNCTION IMPROVEMENTS AT THE END OF THE PHASE 3 LIBERTY ASTHMA QUEST PARENT STUDY
Bourdin, A.
Hanania, N. A.
Dorscheid, D.
Munoz, X.
Tohda, Y.
Daizadeh, N.
Jacob-Nara, J.
Ortiz, B.
Djandji, M.
Deniz, Y.
Rowe, P. J.
THORAX, 2021, 76 : A55 - A57
[37] Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
Wechsler, Michael E.
Ford, Linda B.
Maspero, Jorge F.
Pavord, Ian D.
Papi, Alberto
Bourdin, Arnaud
Watz, Henrik
Castro, Mario
Nenasheva, Natalia M.
Tohda, Yuji
Langton, David
Cardona, Guido
Domingo, Christian
Park, Hae Sim
Chapman, Kenneth R.
Mao, Xuezhou
Zhang, Yi
Khan, Asif H.
Deniz, Yamo
Rowe, Paul J.
Kapoor, Upender
Khokhar, Faisal A.
Mannent, Leda P.
Ruddy, Marcella
Laws, Elizabeth
Amin, Nikhil
Hardin, Megan
LANCET RESPIRATORY MEDICINE, 2022, 10 (01): : 11 - 25
[38] Long-Term Dupilumab Treatment Effect On Safety And Clinical Efficacy In Children With Type 2 Asthma: LIBERTY ASTHMA EXCURSION
Bacharier, Leonard
Maspero, Jorge
Katelaris, Constance
Fiocchi, Alessandro
Gagnon, Remi
de Mir, Ines
Guilbert, Theresa
Jackson, Daniel
Li, Ning
Akinlade, Bolanle
Laws, Elizabeth
Mannent, Leda
Maloney, Jennifer
Tawo, Kelsey
Khokhar, Faisal
Hardin, Megan
Abdulai, Raolat
Lederer, David
Robinson, Lacey
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB15 - AB15
[39] Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST
Maspero, Jorge F.
FitzGerald, John Mark
Pavord, Ian D.
Rice, Megan S.
Maroni, Jaman
Rowe, Paul J.
Pirozzi, Gianluca
Amin, Nikhil
Ruddy, Marcella
Graham, Neil M. H.
Teper, Ariel
Hardin, Megan
ALLERGY, 2021, 76 (08) : 2621 - 2624
[40] Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study
Tohda, Yuji
Nakamura, Yoichi
Fujisawa, Takao
Ebisawa, Motohiro
Arima, Kazuhiko
Miyata, Masanori
Takahashi, Yoshinori
Rice, Megan S.
Deniz, Yamo
Rowe, Paul
Patel, Naimish
Graham, Neil M. H.
Teper, Ariel
ALLERGOLOGY INTERNATIONAL, 2020, 69 (04) : 578 - 587

← 1 2 3 4 5 →